يتناول كتاب جديد الإمكانات العلاجية للفطر السحري في معالجة اضطراب الوسواس القهري، الذي يُطلق عليه غالباً "اضطراب الشك".
يصف مقتطف من الكتاب مشهداً في مدينة نيويورك، حيث يتردد آدم شتراوس في الاختيار بين مشغلي موسيقى (MP3) بينما يمسك بسلك سماعات الرأس الخاص به. ويستند الكتاب إلى فكرة أن الوسواس القهري يرتبط بحالة عدم اليقين، متسائلاً عما إذا كان السيلوسيبين قد يساعد في تقليل هذا الشك.
من إعداد الذكاء الاصطناعي صورة مولدة بواسطة الذكاء الاصطناعي
Researchers at Uppsala University have shown that a short treatment program involving Tetris can reduce intrusive memories in healthcare staff after trauma.
President Donald Trump signed an executive order on Saturday directing federal agencies to accelerate access to psychedelic drugs like psilocybin and ibogaine for treating mental health conditions, including depression, anxiety, and PTSD. The order allocates $50 million in funding and instructs the FDA to prioritize reviews. Trump was joined by Health and Human Services Secretary Robert F. Kennedy Jr., Dr. Mehmet Oz, former Navy SEAL Marcus Luttrell, and podcast host Joe Rogan.
من إعداد الذكاء الاصطناعي
An 83-year-old woman with severe Alzheimer’s disease began speaking in full sentences and regained bladder control after taking a large dose of psilocybin. The changes occurred following a single session with the psychedelic compound derived from magic mushrooms. Researchers describe the case as dramatic but stress it is only one anecdotal report.
Researchers at MIT have discovered that chaotic laser light can self-organize into a highly focused pencil beam, enabling 3D imaging of the blood-brain barrier 25 times faster than current methods. The technique allows real-time observation of drugs entering brain cells without fluorescent tags. This breakthrough could speed up development of treatments for neurological diseases like Alzheimer's and ALS.
من إعداد الذكاء الاصطناعي
A large study tracking nearly 100,000 people in Sweden found that GLP-1 receptor agonists like semaglutide, sold as Ozempic and Wegovy, are associated with significantly fewer psychiatric hospital visits and reduced sick days due to mental health issues. Researchers observed drops of up to 47% in various mental health risks during drug use periods. The findings appear in The Lancet Psychiatry.